Green Signal for First Dengue Vaccine
The Subject Expert Committee of the DCGI has approved the country's first dengue vaccine. This vaccine, known as Qdenga (TAK-003), was developed by Takeda Pharmaceutical Company (Japan). Individuals aged between 4 and 60 years are required to take two doses of this vaccine, administered three months apart. It offers protection against all four serotypes of the dengue virus. The vaccine is expected to become available later this year. Takeda has entered into a partnership with Hyderabad-based firm Bio-E for this initiative.
You Might Also Like
-
Images recently released by NASA, capturing the Earth's "night life," have gone viral. In these i...
-
Passengers on flights are strictly instructed to switch their phones to "Flight Mode." Some peopl...
Leave A Comment
Comments